In vitro anti-tumor activity of the tanshinone IIA against SKOV3 cells

Nat Prod Res. 2016 Aug;30(16):1844-6. doi: 10.1080/14786419.2015.1068774. Epub 2015 Aug 7.

Abstract

The aim of this study was to determine the anti-tumour activity of tanshinone IIA in SKOV3 cells. Results suggested that tanshinone IIA could significantly inhibit (IC50 value = 19.6 μM) the proliferation and induce apoptosis of SKOV3 cells as demonstrated by flow cytometry analysis. In addition, tanshinone IIA treatment induced G2/M phase cell cycle arrest in SKOV3 cells. The results of Western blotting indicated that tanshinone IIA can suppress the expression of anti-apoptotic protein Bcl-2, increase (0.28 vs. 0.62) the expression of pro-apoptotic protein Bax (0.83 vs. 0.24) in SKOV3 cells. It can be concluded that the tanshinone IIA may be a possible therapeutic candidate having cytotoxic and anti-tumour potential.

Keywords: SKOV3; Tanshinone IIA; apoptosis; cell.

MeSH terms

  • Abietanes / pharmacology*
  • Antineoplastic Agents, Phytogenic / pharmacology*
  • Apoptosis / drug effects
  • Cell Cycle Checkpoints / drug effects
  • Cell Line, Tumor
  • Cell Movement / drug effects
  • Cell Proliferation / drug effects
  • Humans
  • Proto-Oncogene Proteins c-bcl-2 / metabolism
  • bcl-2-Associated X Protein / metabolism

Substances

  • Abietanes
  • Antineoplastic Agents, Phytogenic
  • BAX protein, human
  • Proto-Oncogene Proteins c-bcl-2
  • bcl-2-Associated X Protein
  • tanshinone